RUNX1-RUNX1T1 dPCR OncoKit

Detection and quantification of the RUNX1-RUNX1T1 fusion from complementary DNA (cDNA) prepared from peripheral blood

24 rxn (dehydrated/freeze-dried)

Digital PCR

IMG-430

QuantStudioTM Absolute QTM Digital PCR System (ThermoFisher Scientific)

  • Quantitative multiplex assay that allows the detection and quantification of m-BCR-ABL1 fusion in peripheral blood complementary DNA (cDNA).
  • The RUNX1-RUNX1T1 dPCR OncoKit is intended for use in research and is aimed exclusively at healthcare workers and professionals working in molecular biology.

The RUNX1-RUNX1T1 dPCR OncoKit is designed to detect and quantify RUNX1-RUNX1T1 fusion through digital PCR (dPCR), a highly sensitive, precise, and accurate end-point PCR method that allows absolute quantification of a sample that is subdivided into 20,000 partitions.

The kit employs a combination of oligonucleotides and fluorescent hydrolysis probes in a competitive multiplex assay that allows the detection and relative quantification of the fusion of interest in the sample.

  • Type of sample: cDNA from peripheral blood
  • Positive control: synthetic DNA containing the RUNX1-RUNX1T1 fusion and ABL1 region as the endogenous control
  • Limit of detection: 0,01% ± 0.003
  • Limit of quantification: 0,05%
  • Number of reactions per sample: 1
  • Number of targets: 2 (m-BCR fusion and ABL1 region as the endogenous control)
  • dPCR program duration: 1 h 45 min

RUNX1-RUNX1T1 dPCR OncoKit

Fill in the form to request this kit.

Call us at +34 963 212 340

Or write to us at info@healthincode.com

"*" indicates required fields

This field is for validation purposes and should be left unchanged.